These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1087 related items for PubMed ID: 35590083

  • 1. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
    Siemionow M, Langa P, Brodowska S, Kozlowska K, Zalants K, Budzynska K, Heydemann A.
    Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
    [Abstract] [Full Text] [Related]

  • 2. Human dystrophin expressing chimeric (DEC) cell therapy ameliorates cardiac, respiratory, and skeletal muscle's function in Duchenne muscular dystrophy.
    Siemionow M, Langa P, Harasymczuk M, Cwykiel J, Sielewicz M, Smieszek J, Heydemann A.
    Stem Cells Transl Med; 2021 Oct; 10(10):1406-1418. PubMed ID: 34291884
    [Abstract] [Full Text] [Related]

  • 3. Long-Term Biodistribution and Safety of Human Dystrophin Expressing Chimeric Cell Therapy After Systemic-Intraosseous Administration to Duchenne Muscular Dystrophy Model.
    Siemionow M, Brodowska S, Langa P, Zalants K, Kozlowska K, Grau-Kazmierczak W, Heydemann A.
    Arch Immunol Ther Exp (Warsz); 2022 Aug 17; 70(1):20. PubMed ID: 35978142
    [Abstract] [Full Text] [Related]

  • 4. Cardiac Protection after Systemic Transplant of Dystrophin Expressing Chimeric (DEC) Cells to the mdx Mouse Model of Duchenne Muscular Dystrophy.
    Siemionow M, Malik M, Langa P, Cwykiel J, Brodowska S, Heydemann A.
    Stem Cell Rev Rep; 2019 Dec 17; 15(6):827-841. PubMed ID: 31612351
    [Abstract] [Full Text] [Related]

  • 5. Transplantation of Dystrophin Expressing Chimeric Human Cells of Myoblast/Mesenchymal Stem Cell Origin Improves Function in Duchenne Muscular Dystrophy Model.
    Siemionow M, Szilagyi E, Cwykiel J, Domaszewska-Szostek A, Heydemann A, Garcia-Martinez J, Siemionow K.
    Stem Cells Dev; 2021 Feb 17; 30(4):190-202. PubMed ID: 33349121
    [Abstract] [Full Text] [Related]

  • 6. Chimeric Cell Therapy Transfers Healthy Donor Mitochondria in Duchenne Muscular Dystrophy.
    Siemionow M, Bocian K, Bozyk KT, Ziemiecka A, Siemionow K.
    Stem Cell Rev Rep; 2024 Oct 17; 20(7):1819-1829. PubMed ID: 39017908
    [Abstract] [Full Text] [Related]

  • 7. Amelioration of Morphological Pathology in Cardiac, Respiratory, and Skeletal Muscles Following Intraosseous Administration of Human Dystrophin Expressing Chimeric (DEC) Cells in Duchenne Muscular Dystrophy Model.
    Siemionow M, Budzynska K, Zalants K, Langa P, Brodowska S, Siemionow K, Heydemann A.
    Biomedicines; 2024 Mar 06; 12(3):. PubMed ID: 38540201
    [Abstract] [Full Text] [Related]

  • 8. Dystrophin Expressing Chimeric (DEC) Human Cells Provide a Potential Therapy for Duchenne Muscular Dystrophy.
    Siemionow M, Cwykiel J, Heydemann A, Garcia J, Marchese E, Siemionow K, Szilagyi E.
    Stem Cell Rev Rep; 2018 Jun 06; 14(3):370-384. PubMed ID: 29546607
    [Abstract] [Full Text] [Related]

  • 9. Creation of Dystrophin Expressing Chimeric Cells of Myoblast Origin as a Novel Stem Cell Based Therapy for Duchenne Muscular Dystrophy.
    Siemionow M, Cwykiel J, Heydemann A, Garcia-Martinez J, Siemionow K, Szilagyi E.
    Stem Cell Rev Rep; 2018 Apr 06; 14(2):189-199. PubMed ID: 29305755
    [Abstract] [Full Text] [Related]

  • 10. Chimeric Cell Therapies as a Novel Approach for Duchenne Muscular Dystrophy (DMD) and Muscle Regeneration.
    Budzynska K, Siemionow M, Stawarz K, Chambily L, Siemionow K.
    Biomolecules; 2024 May 13; 14(5):. PubMed ID: 38785982
    [Abstract] [Full Text] [Related]

  • 11. Dystrophin Expressing Chimeric (DEC) Cell Therapy for Duchenne Muscular Dystrophy: A First-in-Human Study with Minimum 6 Months Follow-up.
    Heydemann A, Bieganski G, Wachowiak J, Czarnota J, Niezgoda A, Siemionow K, Ziemiecka A, Sikorska MH, Bozyk K, Tullius SG, Siemionow M.
    Stem Cell Rev Rep; 2023 Jul 13; 19(5):1340-1359. PubMed ID: 37000376
    [Abstract] [Full Text] [Related]

  • 12. Cell transplantation-mediated dystrophin supplementation efficacy in Duchenne muscular dystrophy mouse motor function improvement demonstrated by enhanced skeletal muscle fatigue tolerance.
    Bourgeois Yoshioka CK, Takenaka-Ninagawa N, Goto M, Miki M, Watanabe D, Yamamoto M, Aoyama T, Sakurai H.
    Stem Cell Res Ther; 2024 Sep 19; 15(1):313. PubMed ID: 39300595
    [Abstract] [Full Text] [Related]

  • 13. Intraosseous transplant of dystrophin expressing chimeric (DEC) cells improves skeletal muscle function in mdx mouse model of Duchenne muscular dystrophy.
    Malik M, Siemionow M, Cwykiel J, Heydemann A, Garcia-Martinez J, Siemionow K, Szilagyi E.
    Postepy Kardiol Interwencyjnej; 2022 Dec 19; 18(4):399-406. PubMed ID: 36967847
    [Abstract] [Full Text] [Related]

  • 14. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE, Trieu J, Chee A, Naim T, Gehrig SM, Lamon S, Angelini C, Russell AP, Lynch GS.
    Exp Physiol; 2014 Apr 19; 99(4):675-87. PubMed ID: 24443351
    [Abstract] [Full Text] [Related]

  • 15. Pannexin 1 dysregulation in Duchenne muscular dystrophy and its exacerbation of dystrophic features in mdx mice.
    Freeman E, Langlois S, Leyba MF, Ammar T, Léger Z, McMillan HJ, Renaud JM, Jasmin BJ, Cowan KN.
    Skelet Muscle; 2024 Apr 26; 14(1):8. PubMed ID: 38671506
    [Abstract] [Full Text] [Related]

  • 16. Immunomodulatory amnion-derived mesenchymal stromal cells preserve muscle function in a mouse model of Duchenne muscular dystrophy.
    Nitahara-Kasahara Y, Nakayama S, Kimura K, Yamaguchi S, Kakiuchi Y, Nito C, Hayashi M, Nakaishi T, Ueda Y, Okada T.
    Stem Cell Res Ther; 2023 Apr 27; 14(1):108. PubMed ID: 37106393
    [Abstract] [Full Text] [Related]

  • 17. The X-linked Becker muscular dystrophy (bmx) mouse models Becker muscular dystrophy via deletion of murine dystrophin exons 45-47.
    Heier CR, McCormack NM, Tully CB, Novak JS, Newell-Stamper BL, Russell AJ, Fiorillo AA.
    J Cachexia Sarcopenia Muscle; 2023 Apr 27; 14(2):940-954. PubMed ID: 36628607
    [Abstract] [Full Text] [Related]

  • 18. Sphingosine Phosphate Lyase Is Upregulated in Duchenne Muscular Dystrophy, and Its Inhibition Early in Life Attenuates Inflammation and Dystrophy in Mdx Mice.
    De la Garza-Rodea AS, Moore SA, Zamora-Pineda J, Hoffman EP, Mistry K, Kumar A, Strober JB, Zhao P, Suh JH, Saba JD.
    Int J Mol Sci; 2022 Jul 08; 23(14):. PubMed ID: 35886926
    [Abstract] [Full Text] [Related]

  • 19. Sunitinib inhibits STAT3 phosphorylation in cardiac muscle and prevents cardiomyopathy in the mdx mouse model of Duchenne muscular dystrophy.
    Oliveira-Santos A, Dagda M, Burkin DJ.
    Hum Mol Genet; 2022 Jul 21; 31(14):2358-2369. PubMed ID: 35157045
    [Abstract] [Full Text] [Related]

  • 20. Isometric resistance training increases strength and alters histopathology of dystrophin-deficient mouse skeletal muscle.
    Lindsay A, Larson AA, Verma M, Ervasti JM, Lowe DA.
    J Appl Physiol (1985); 2019 Feb 01; 126(2):363-375. PubMed ID: 30571283
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.